Barrett's Esophagus Clinical Trials

A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 349 clinical trials
IMAGING OF PRIMARY OR RECURRENT GYNECOLOGICAL CANCER WITH [18F]FLUORTHANATRACE ([18F]FTT) PET/CT

Participants will undergo up to three [18F]FTT PET/CT scans. A baseline scan will be done prior to starting therapy. A second [18F]FTT PET/CT scan may be done 1-21 days after initiation of therapy to collect pilot data on the changes in FTT uptake with therapy.

  • 0 views
  • 19 Feb, 2024
  • 1 location
EVALUATION OF PATIENT OUTCOMES FROM THE KIDNEY ALLOGRAFT OUTCOMES ALLOSURE REGISTRY (KOAR)

A matched control cohort of 300 patients will be retrospectively selected from the subset of centers providing the test cohort patients who have planned surveillance biopsies at 12 months post-transplantation.

  • 0 views
  • 19 Feb, 2024
  • 1 location
ADP-0000-002: Long Term Follow-up of Subjects Exposed to NY-ESO-1c259 T A Genetically Engineered NY-ESO-1 Specific T Cell Receptor

Subjects will undergo clinical evaluation with careful attention to adverse events possibly related to gene transfer/lentivirus-induced diseases. Blood samples will be collected. Subjects will be followed for survival.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Three Approaches to Maintenance Therapy for Chronic Insomnia in Older Adults (R01AG054521)

., partial reinforcement following the obtention of treatment response with standard treatment) with a particular focus on 1) how low a dose may be used (dose = frequency of active medication) and 2) how long low frequency dosing may be used to maintain treatment response.

  • 0 views
  • 19 Feb, 2024
  • 1 location
A single-arm open-label phase 2 study evaluating the efficacy and safety of abemaciclib in patients with recurrent oligodendroglioma

The study will enroll 10 subjects who are evaluable for the studys primary endpoint (subjects must be receive at least one dose of abemacicilb to be evaluable for the primary endpoint). The study will be stratified by number of lines of prior alkylating chemotherapy (one prior line versus two or …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Basis: Evaluating Sirtuin Supplements To Benefit Elderly Trauma Patients (BES2T BET)

This randomized, double blind placebo controlled trial will investigate the impact of Basis on the functional recovery of elderly patients (65 years or older) admitted to the trauma service post-injury. Basis (or placebo) will be taken orally for 90 days. Bioactivity will be tracked daily. Functional, cognitive, and biochemical assays …

  • 0 views
  • 19 Feb, 2024
  • 1 location
CEA for the delineation of primary and recurrent tumor and metastases in patients undergoing curative surgery for colorectal cancer

The purposes of this study are to test the effectiveness of the study drug, SGM-101 to allow the doctor who will perform the surgery to remove your cancer to see better which tissue is cancer and which is healthy so that the surgery can be performed more precisely to get …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Multimodal imaging outcome measures for ALS (Image ALS)

  We need data from people with ALS. If you agree to be in this study, you will have up to 6 PET/CT scans over 3 study visits within about a 6-month period.  A blood sample will be taken before the scans.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Determination of B-cell responsiveness to the incretin hormones GLP-1 and GIP in Cystic Fibrosis (PRIME)

The mechanisms underlying cystic fibrosis related diabetes (CFRD) pathophysiology must be better defined if care for people with CFRD is to be optimized or if development of CFRD is to be interrupted. Detailed studies of insulin secretion in CF are required to achieve this goal since 1) subtle insulin secretion …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure

Randomized (flip of the coin 50/50) study of heart failure (HF) patients with moderate aortic valve stenosis (narrowing) will be either treated with a transcatheter valve replacement (TAVR) or continue with medical management. Subjects will be followed for 2 years.

  • 0 views
  • 19 Feb, 2024
  • 1 location